27/08/2026
PRP (platelet-rich plasma) in the vulvovaginal area is proposed to help because platelets release growth factors and signalling proteins that may support tissue repair, angiogenesis and local tissue remodelling.
But an important point: PRP is not yet an established first-line treatment for most vulvovaginal disorders. The quality of evidence varies considerably, studies are often small, and preparation methods, platelet concentrations and treatment protocols are not yet standardised.
Medicine and science progress through research, clinical experience and well-designed trials. Every carefully conducted study helps us better understand who may benefit, how PRP should be prepared and administered, and where it truly has a role.
Help us help medicine and science grow through evidence, experience and research